Neurizon Therapeutics LimitedASX: NUZ

Section 708A Cleansing Statement

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 2 pages · English

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com 9 November 2026 Section 708A Cleansing Statement This notice is given by Neurizon Therapeutics Limited ACN 094 006 023 (ASX: NUZ) (Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). The Company...

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

All Neurizon Therapeutics news releases